Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Constitutive activation of the Ras/MAP kinase pathway and enhanced TCR signaling by targeting the Shc adaptor to membrane rafts

Abstract

The Shc adaptor is responsible for coupling receptor tyrosine kinases and tyrosine kinase-associated receptors to the Ras/MAP kinase pathway. Shc is believed to be regulated by a change in subcellular localization from the cytosol to the plasma membrane, where it recruits Grb-2/Sos complexes and hence permits juxtaposition of the guanine nucleotide exchange factor Sos to Ras, resulting in GDP/GTP exchange and Ras activation. Shc has been recently shown to inducibly colocalize in detergent-resistant membrane rafts together with the activated TCR and associated signaling molecules. To understand whether Shc localization in membrane rafts is sufficient to regulate Shc function, we constructed a Shc chimera containing the Ras membrane localization motif at the C-terminus. We show that membrane targeted Shc was constitutively localized in the plasma membrane of T-cells, and was mostly compartmentalized in lipid rafts. Membrane targeted Shc was phosphorylated on tyrosine residues and bound Grb-2/Sos in the absence of TCR engagement. Furthermore, expression of membrane targeted Shc resulted in constitutive downstream signaling, including Erk2 activation and enhancement of TCR dependent activation of the TCR responsive transcription factor NF-AT. Hence localization of Shc in membrane rafts is sufficient for Shc to acquire a signaling competent state. Interestingly, a membrane targeted Shc mutant lacking both Grb-2 binding sites was not only incapable of signaling in the absence of TCR triggering, but transdominantly inhibited endogenous Shc, supporting a non redundant role for Shc in the activation of the Ras/MAP kinase pathway in T-cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

Abbreviations

PTK:

protein tyrosine kinase

TCR:

T-cell antigen receptor

MAP:

mitogen activated protein

ITAM:

immunoreceptor tyrosine-based activation motif

PTB:

phosphotyrosine binding

CH:

collagen homology

PMA:

phorbol myristate acetate

References

  • Aronheim A, Engelberg D, Li N, al-Alawi N, Schlessinger J and Karin M . 1994 Cell 78: 949–961

  • Baldari CT, Heguy A and Telford JL . 1993 J Biol Chem 268: 2693–2698

  • Baldari CT, Pelicci G, Di Somma MM, Milia E, Giuli S, Pelicci PG and Telford JL . 1995 Oncogene 10: 1141–1147

  • Baldari CT and Telford JL . 1999 Biol Chem 380: 129–134

  • Bonfini L, Migliaccio E, Pelicci G, Lanfrancone L and Pelicci PG . 1996 TIBS 21: 257–261

  • Bordier C . 1981 J Biol Chem 256: 1604–1607

  • Chen RH, Corbalan-Garcia S and Bar-Sagi D . 1997 EMBO J 16: 1351–1359

  • Crabtree GR and Clipstone NA . 1994 Annu Rev Biochem 63: 1045–1083

  • Duplay P, Thome M, Herve F and Acuto O . 1994 J Exp Med 179: 1163–1172

  • Genot E, Cleverley S, Henning S and Cantrell D . 1996 EMBO J 15: 3923–3933

  • Gotoh N, Tojo A and Shibuya M . 1996 EMBO J 15: 6197–6204

  • Graef IA, Holsinger LJ, Diver S, Schreiber SL and Crabtree GL . 1997 EMBO J 16: 5618–5628

  • Hancock JF, Cadwallader K, Paterson H and Marshall CJ . 1991 EMBO J 10: 4033–4039

  • Harmer SL and DeFranco AL . 1997 Mol Cell Biol 17: 4087–4095

  • Holsinger LJ, Spencer DM, Austin DJ, Schreiber SL and Crabtree GR 1995 . Proc Natl Acad Sci USA 92: 9810–9814

  • Iwashima M, Irving BA, van Oers N, Chan AC and Weiss A . 1994 Science 263: 1136–1139

  • Koretzky GA . 1997 Immunol Today 8: 401–406

  • Magee T and Marshall C . 1999 Cell 98: 9–12

  • Marshall CJ . 1994 Curr Opin Genet Dev 4: 82–8

  • McCormick F . 1993 Nature 363: 15–16

  • Milia E, Di Somma MM, Baldoni F, Chiari R, Lanfrancone L, Pelicci PG, Telford JL and Baldari CT . 1996 Oncogene 13: 767–775

  • Montixi C, Langlet C, Bernard AM, Thimonier J, Dubois C, Wurbel MA, Chauvin JP, Pierres M and He HT . 1998 EMBO J 17: 5334–5348

  • Neumeister EN, Zhu Y, Richard S, Terhost C, Chan AC and Shaw AS . 1995 Mol Cell Biol 15: 3171–3178

  • Pacini S, Ulivieri C, Di Somma MM, Isacchi A, Lanfrancone L, Pelicci PG, Telford JL and Baldari CT . 1998 J Biol Chem 273: 20487–20493

  • Pawson T . 1995 Nature 373: 573–580

  • Peterson EJ, Clements JL, Fang N and Koretzky GA . 1998 Curr Opin Immunol 10: 337–344

  • Ravichandran K, Lee KK, Songyang Z, Cantley LC, Burn P and Burakoff SJ . 1993 Science 262: 902–905

  • Ravichandran K, Lorenz U, Shoelson SE and Burakoff SJ . 1995 Mol Cell Biol 15: 593–600

  • Ravichandran KS, Zhou MM, Pratt JC, Harlan JA, Walk SF, Fesik SW and Burakoff SJ . 1997 Mol Cell Biol 17: 5540–5549

  • Rudd CE . 1999 Cell 96: 5–8

  • Simons K and Ikonen E . 1997 Nature 387: 569–572

  • Ulivieri C, Pacini S, Bartalini S, Valensin S, Telford JL and Baldari CT . 1999 Eur J Immunol 29: in press

  • Walk SF, March ME and Ravichandran KS . 1998 Eur J Immunol 28: 2265–2275

  • Wange RL and Samelson LE . 1996 Immunity 5: 197–205

  • Weiss A and Littman DR . 1994 Cell 76: 263–274

  • Wessel D and Flugge UL . 1983 Anal Biochem 138: 141–143

  • Woodrow MA, Rayter S, Downward J and Cantrell DA 1993a . J Immunol 150: 3853–3861

  • Xavier R, Brennan T, Li Q, McCormack C and Seed B . 1998 Immunity 8: 723–732

  • Yamasaki S, Takamatsu M and Iwashima M . 1996 Mol Cell Biol 16: 7151–7160

  • Zhang W, Sloan-Lancaster J, Kitchen J, Trible RP and Samelson LE . 1998 Cell 92: 83–92

Download references

Acknowledgements

The authors wish to acknowledge S Grassini for technical assistance, L Gamberucci for contribution to the artwork, and G Benocci for secretarial assistance. They also indebted to T Pawson for the generous gift of the HA-tagged Shc cDNA and to JL Telford for productive discussions, helpful advise and critical reading of the manuscript. This work was generously supported by the Italian Association for Cancer Research (AIRC) and Telethon (grant n. E.651). The contribution of the MURST (quota 60 and 40%) is also gratefully acknowledged. S Plyte is the recipient of an EMBO long-term fellowship. MB Majolini and S Pacini are the recipients of a fellowship from the Italian Federation for Cancer Research (FIRC).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Plyte, S., Majolini, M., Pacini, S. et al. Constitutive activation of the Ras/MAP kinase pathway and enhanced TCR signaling by targeting the Shc adaptor to membrane rafts. Oncogene 19, 1529–1537 (2000). https://doi.org/10.1038/sj.onc.1203451

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203451

Keywords

This article is cited by

Search

Quick links